Researchers

IDA Hiroshi

IDA Hiroshi
Lecturer in Medical School
Faculty Department of Medicine
Researchmap https://researchmap.jp/hidakuhp

Education and Career

Academic & Professional Experience

  • 2009 - 2010 , Kyoto University 医学(系)研究科(研究院) 助教

Research Activities

Research Areas

  • Life sciences, Gastroenterology

Research Interests

B型肝炎, C型肝炎, 肝細胞癌, 膵液, 胆汁, 膵液・胆汁, DNAメチル化, RUNX3

Published Papers

  1. Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma.
    Tomoko Aoki; Masatoshi Kudo; Kazuomi Ueshima; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Hiroshi Ida; Yasunori Minami; Masakatsu Tsurusaki; Naoshi Nishida
    Liver cancer  13  (1)  , 56-69, Feb. 2024 
  2. Fontan術後に発症した切除不能肝細胞癌の1例
    萩原 智; 上嶋 一臣; 西田 直生志; 依田 広; 三長 孝輔; 南 康範; 田北 雅弘; 青木 智子; 盛田 真弘; 千品 寛和; 松原 卓哉; 大丸 直哉; 稲村 昇; 工藤 正俊
    肝臓  64  (11)  , 567-574, Nov. 2023 
  3. Fontan術後に発症した切除不能肝細胞癌の1例
    萩原 智; 上嶋 一臣; 西田 直生志; 依田 広; 三長 孝輔; 南 康範; 田北 雅弘; 青木 智子; 盛田 真弘; 千品 寛和; 松原 卓哉; 大丸 直哉; 稲村 昇; 工藤 正俊
    肝臓  64  (11)  , 567-574, Nov. 2023 

MORE

MISC

  1. Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis , Masatoshi Kudo; Kazuomi Ueshima; Shin Nakahira; Naoshi Nishida; Hiroshi Ida; Yasunori Minami; Takuya Nakai; Hiroshi Wada; Shoji Kubo; Kazuyoshi Ohkawa; Asahiro Morishita; Takeo Nomi; Koji Ishida; Shogo Kobayashi; Makoto Umeda; Masakatsu Tsurusaki; Yasutaka Chiba; Kenichi Yoshimura; Kazuko Sakai; Kazuto Nishio , JOURNAL OF CLINICAL ONCOLOGY , 40 , 4 , Feb. 2022
  2. リザーバー留置後に胃よりカテーテルの逸脱を認めた一例 , 大丸直哉; 田北雅弘; 浦瀬篤史; 千品寛和; 青木智子; 萩原智; 依田広; 上嶋一臣; 鶴崎正勝; 鶴崎正勝; 西田直生志; 工藤正俊 , リザーバー&ポート研究会プログラム・抄録集 , 46th , 2022
  3. Adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. , Masatoshi Kudo; Kazuomi Ueshima; Shin Nakahira; Naoshi Nishida; Hiroshi Ida; Yasunori Minami; Takuya Nakai; Hiroshi Wada; Shoji Kubo; Kazuyoshi Ohkawa; Asahiro Morishita; Takeo Nomi; Koji Ishida; Shogo Kobayashi; Makoto Umeda; Masakatsu Tsurusaki; Yasutaka Chiba; Kenichi Yoshimura; Kazuko Sakai; Kazuto Nishio , JOURNAL OF CLINICAL ONCOLOGY , 39 , 15 , May. 2021

MORE

Research Grants & Projects

  1. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Development of detection of methylation of multiple tumor suppressor genes and its clinical application. , Kyoto University